Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans

Infection and Immunity

Volumn 79, Issue 5, 2011, Pages 1915-1926

  Arora, Shikha ^a   Olszewski, Michal A ^a,b   Tsang, Tiffany M ^a   McDonald, Roderick A ^a   Toews, Galen B ^a,b   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4;

ALLERGIC BRONCHOPULMONARY MYCOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISEASE SEVERITY; FEMALE; FUNGAL CLEARANCE; IMMUNE RESPONSE; KINETICS; LUNG MYCOSIS; MACROPHAGE POLARIZATION; MICROBIOLOGICAL PARAMETERS; MOUSE; MYCOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; STEADY STATE; TH1 CELL; TH2 CELL; UPREGULATION; WILD TYPE;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; LUNG DISEASES, FUNGAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS;

EID: 79955642451     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01270-10     Document Type: Article

References (43)

1. Alspaugh, J. A., and D. L. Granger. 1991. Inhibition of Cryptococcus neo-formans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59:2291-2296.
2. Arora, S., et al. 2005. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic broncho-pulmonary mycosis. J. Immunol. 174:6346-6356.
3. Beamer, G. L., et al. 2008. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J. Immunol. 181:5545-5550.
4. Bhan, U., et al. 2008. Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect. Immun. 76:2895-2904.
5. Brys, L., et al. 2005. Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J. Immunol. 174:6095-6104.
6. Chen, G. H., et al. 2008. Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect. Immun. 76:2379-2391.
7. Chen, G. H., et al. 2007. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am. J. Pathol. 170:1028-1040.
8. Diaz, Y. R., R. Rojas, L. Valderrama, and N. G. Saravia. 2010. T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species. J. Infect. Dis. 202:406-415.
9. Edwards, L., et al. 2005. Stimulation via Toll-like receptor 9 reduces Cryp-tococcus neoformans-induced pulmonary inflammation in an IL-12-depen-dent manner. Eur. J. Immunol. 35:273-281.
10. El Kasmi, K. C., et al. 2008. Toll-like receptor-induced arginase 1 in mac-rophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9:1399-1406.
11. Fink, L., et al. 1998. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat. Med. 4:1329-1333.
12. Goldman, D., Y. Cho, M. Zhao, A. Casadevall, and S. C. Lee. 1996. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neo-formans granulomas. Am. J. Pathol. 148:1275-1282.
13. Goldman, D. L., S. C. Lee, A. J. Mednick, L. Montella, and A. Casadevall. 2000. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide syn-thase expression, and altered antibody responsiveness to cryptococcal poly-saccharide. Infect. Immun. 68:832-838.
14. Granger, D. L., J. B. Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of mu-rine macrophages. J. Clin. Invest. 85:264-273.
15. Granger, D. L., J. B. Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1988. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Invest. 81:1129-1136.
16. Hardison, S. E., et al. 2010. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am. J. Pathol. 176:774-785.
17. Hartl, D., K. F. Buckland, and C. M. Hogaboam. 2006. Chemokines in allergic aspergillosis-from animal models to human lung diseases. Inflamm. Allergy Drug Targets 5:219-228.
18. Hernandez, Y., et al. 2005. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J. Immunol. 174:1027-1036.
19. Herring, A. C., et al. 2005. Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect. Immun. 73:39-49.
20. Huffnagle, G. B., M. B. Boyd, N. E. Street, and M. F. Lipscomb. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
21. Huffnagle, G. B., et al. 1997. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318-327.
22. Huffnagle, G. B., et al. 1996. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529-4536.
23. Jakubzick, C., et al. 2004. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am. J. Pathol. 165:1211-1221.
24. Katakura, T., M. Miyazaki, M. Kobayashi, D. N. Herndon, and F. Suzuki. 2004. CCL17 and IL-10 as effectors that enable alternatively activated mac-rophages to inhibit the generation of classically activated macrophages. J. Immunol. 172:1407-1413.
25. Loke, P., et al. 2002. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 3:7.
26. Manicone, A. M., K. M. Burkhart, B. Lu, and J. G. Clark. 2008. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp. Lung Res. 34:391-407.
27. Mantovani, A., et al. 2004. The chemokine system in diverse forms of mac-rophage activation and polarization. Trends Immunol. 25:677-686.
28. Milam, J. E., et al. 2007. Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector. Infect. Immun. 75:4951-4958.
29. Motta, A. C., et al. 2010. The recurrence of leprosy reactional episodes could be associated with oral chronic infections and expression of serum IL-1, TNF-alpha, IL-6, IFN-gamma and IL-10. Braz. Dent. J. 21:158-164.
30. Muller, U., et al. 2008. A gene-dosage effect for interleukin-4 receptor alpha-chain expression has an impact on Th2-mediated allergic inflammation during bronchopulmonary mycosis. J. Infect. Dis. 198:1714-1721.
31. Muller, U., et al. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179: 5367-5377.
32. Nair, M. G., D. W. Cochrane, and J. E. Allen. 2003. Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunol. Lett. 85:173-180.
33. Nishioka, Y., et al. 2007. CXCL9 and 11 in patients with pulmonary sarcoid-osis: a role of alveolar macrophages. Clin. Exp. Immunol. 149:317-326.
34. Olszewski, M. A., et al. 2000. The role of macrophage inflammatory protein-1alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J. Immunol. 165:6429-6436.
35. Osterholzer, J. J., et al. 2009. Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am. J. Pathol. 174:932-943.
36. Raes, G., et al. 2002. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71:597-602.
37. Raes, G., et al. 2005. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 174:6561; author reply, 6561-6562.
38. -/- mice mount an efficient Th1 response but fail to control Leishmania major infection. Eur. J. Immunol. 35:515-523.
39. Stenzel, W., et al. 2009. IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am. J. Pathol. 174:486-496.
40. Ward, J. M., et al. 2001. Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129S4/SvJae and wild-type and CYP1A2-null B6, 129 mice. Am. J. Pathol. 158:323-332.
41. Zhang, Y., et al. 2010. TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am. J. Pathol. 177:754-765.
42. Zhang, Y., et al. 2009. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am. J. Pathol. 175:2489-2500.
43. Zhao, J., H. Zhu, C. H. Wong, K. Y. Leung, and W. S. Wong. 2005. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics 5:2799-2807.